Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions
NCT03022877
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Rationale obsolete
Conditions
Myocardial Infarction
Outcome
Interventions
DRUG:
Levosimendan
Sponsor
RWTH Aachen University